Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← David Einhorn, latest 13F

NeuBase Therapeutics

In David Einhorn's portfolio · Greenlight Capital

Ticker NBSE

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2024 Sell 0  
Q1 2024 No change 136,350 0.0% $0.45 $61K
Q4 2023 No change 136,350 0.0% $0.74 $101K
Q3 2023 No change 136,350 0.0% $0.87 $119K
Q2 2023 Reduce 95% 136,350 0.0% $1.87 $255K
Q1 2023 No change 2,727,027 0.0% $0.19 $504K
Q4 2022 No change 2,727,027 0.0% $0.19 $519K
Q3 2022 No change 2,727,027 0.1% $0.39 $1.1M
Q2 2022 No change 2,727,027 0.2% $1.05 $2.9M
Q1 2022 No change 2,727,027 0.3% $1.88 $5.1M
Q4 2021 No change 2,727,027 0.4% $2.81 $7.7M
Q3 2021 No change 2,727,027 0.7% $3.61 $9.8M
Q2 2021 Add 35% 2,727,027 0.8% $4.79 $13.1M
Q1 2021 No change 2,027,027 1.0% $7.39 $15.0M
Q4 2020 No change 2,027,027 0.9% $6.99 $14.2M
Q3 2020 Add 7% 2,027,027 1.3% $7.59 $15.4M
Q2 2020 Add 24% 1,903,227 1.8% $8.78 $16.7M
Q1 2020 No change 1,538,462 1.6% $7.12 $11.0M
Q4 2019 No change 1,538,462 0.8% $7.20 $11.1M
Q3 2019 Buy 1,538,462 0.6% $4.99 $7.7M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.